Neurogene, Inc. (NGNE)
28.31
-2.94
(-9.41%)
USD |
NASDAQ |
Sep 25, 16:00
28.32
+0.01
(+0.04%)
After-Hours: 19:59
Neurogene Price to Book Value : 2.064 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 2.064 |
| September 24, 2026 | 2.278 |
| September 23, 2026 | 2.255 |
| September 22, 2026 | 2.450 |
| September 21, 2026 | 2.375 |
| September 18, 2026 | 2.340 |
| September 17, 2026 | 2.363 |
| September 16, 2026 | 2.528 |
| September 15, 2026 | 2.456 |
| September 14, 2026 | 2.567 |
| September 11, 2026 | 2.587 |
| September 10, 2026 | 2.633 |
| September 09, 2026 | 2.762 |
| September 08, 2026 | 2.780 |
| September 04, 2026 | 2.814 |
| September 03, 2026 | 2.742 |
| September 02, 2026 | 2.797 |
| September 01, 2026 | 2.761 |
| August 31, 2026 | 2.642 |
| August 28, 2026 | 2.667 |
| August 27, 2026 | 2.760 |
| August 26, 2026 | 2.800 |
| August 25, 2026 | 2.978 |
| August 24, 2026 | 2.89 |
| August 21, 2026 | 2.816 |
| Date | Value |
|---|---|
| August 20, 2026 | 2.770 |
| August 19, 2026 | 2.875 |
| August 18, 2026 | 2.601 |
| August 17, 2026 | 2.674 |
| August 14, 2026 | 2.635 |
| August 13, 2026 | 2.598 |
| August 12, 2026 | 2.696 |
| August 11, 2026 | 2.610 |
| August 10, 2026 | 2.665 |
| August 07, 2026 | 2.602 |
| August 06, 2026 | 2.596 |
| August 05, 2026 | 2.623 |
| August 04, 2026 | 2.509 |
| August 03, 2026 | 2.396 |
| July 31, 2026 | 2.398 |
| July 30, 2026 | 2.450 |
| July 29, 2026 | 2.454 |
| July 28, 2026 | 2.422 |
| July 27, 2026 | 2.524 |
| July 24, 2026 | 2.544 |
| July 23, 2026 | 2.593 |
| July 22, 2026 | 2.633 |
| July 21, 2026 | 2.674 |
| July 20, 2026 | 2.722 |
| July 17, 2026 | 2.720 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.724 |
| Alnylam Pharmaceuticals, Inc. | 25.28 |
| Anika Therapeutics, Inc. | 1.986 |
| Savara, Inc. | 7.149 |
| Vericel Corp. | 5.491 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2731 |
| Price | 28.31 |
| Earnings Yield | -19.44% |
| Market Cap | 448.16M |
| PEGY Ratio | -0.2731 |